SCHEMBL17548822

SCHEMBL17548822

Brc1cccc2sc3cc4c(cc3c12)c1ccccc1n4-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.36
▸ MEN1 O00255 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ PDE1B Q01064 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ PDE11A Q9HCR9 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ BRCA1 P38398 1/20 0.31
▸ HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20159371 0.87 KDM4E (0.33) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL17253020 0.86 ATM (0.43) ATML3MBTL1KDM4EHSD17B10MEN1
SCHEMBL16999751 0.83 ATM (0.62) ATML3MBTL1KDM4EHSD17B10MEN1
SCHEMBL10014522 0.82 L3MBTL1 (0.56) ATML3MBTL1KDM4EHSD17B10MEN1
SCHEMBL23559227 0.82 KDM4E (0.38) ATML3MBTL1KDM4EHSD17B10HDAC4
SCHEMBL20935690 0.81 L3MBTL1 (0.36) ATML3MBTL1KDM4EHSD17B10ALDH1A1
SCHEMBL18910376 0.81 KDM4E (0.37) ATML3MBTL1KDM4EHDAC4
SCHEMBL18381862 0.81 L3MBTL1 (0.55) ATML3MBTL1KDM4EHSD17B10MEN1
SCHEMBL18868345 0.81 L3MBTL1 (0.55) ATML3MBTL1KDM4EHSD17B10MEN1
SCHEMBL22140889 0.81 ATM (0.39) ATML3MBTL1KDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed
WO-2016032150-A2 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2016-03-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME ORAI2, VDAC2, PIEZO1 ATM 2903/4885L3MBTL1 783/4885KDM4E 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback